Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.8399
-0.0855 (-9.24%)
At close: Nov 20, 2026, 4:00 PM EST
0.8700
+0.0301 (3.58%)
After-hours: Nov 20, 2026, 7:51 PM EST
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $150.58 million as of November 20, 2026. It is the 21,819th most valuable company in the world and the 3,674th biggest in the United States. Its market cap has decreased by 53.43% in one year.
Market Cap
150.58M
Enterprise Value
36.96M
1-Year Change
-53.43%
Global Rank
Country Rank
#3,674 United States
Category
ChartMarket Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $150.58M, an increase of 100.58%. That is a compound annual growth rate of 13.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 150.58M | -57.00% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 184.70M |
| Entrada Therapeutics | 183.63M |
| Vogenx | 183.31M |
| Sol-Gel Technologies | 174.83M |
| Eledon Pharmaceuticals | 171.62M |
| Korro Bio | 170.75M |
| Oramed Pharmaceuticals | 169.16M |
| Pyxis Oncology | 168.65M |